These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 27992687

  • 1. Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
    Comte D, Karampetsou MP, Kis-Toth K, Yoshida N, Bradley SJ, Kyttaris VC, Tsokos GC.
    Arthritis Rheumatol; 2017 Apr; 69(4):808-813. PubMed ID: 27992687
    [Abstract] [Full Text] [Related]

  • 2. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ.
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [Abstract] [Full Text] [Related]

  • 3. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
    Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Kang I.
    Arthritis Res Ther; 2010 Sep; 12(2):R53. PubMed ID: 20334681
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM, Urra JM, Carreño A, Zamorano J.
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [Abstract] [Full Text] [Related]

  • 5. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z, Tian Z, Zhang M, Zhang Y, Ni B, Hao F.
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [Abstract] [Full Text] [Related]

  • 6. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Jul; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 7. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z, Wong CK, Kam NW, Dong J, Jiao D, Chu M, Lam CW, Tam LS.
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [Abstract] [Full Text] [Related]

  • 9. IL-22 production of effector CD4+ T-cells is altered in SLE patients.
    Dolff S, Scharpenberg C, Specker C, Kribben A, Witzke O, Wilde B.
    Eur J Med Res; 2019 Jul 22; 24(1):24. PubMed ID: 31331400
    [Abstract] [Full Text] [Related]

  • 10. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R, Müllegger D, Skriner K, Jahn-Schmid B, Smolen JS, Steiner G.
    Arthritis Res Ther; 2006 Jul 22; 8(4):R118. PubMed ID: 16859514
    [Abstract] [Full Text] [Related]

  • 11. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
    Sippl N, Faustini F, Rönnelid J, Turcinov S, Chemin K, Gunnarsson I, Malmström V.
    Clin Exp Immunol; 2021 Jul 22; 205(1):44-52. PubMed ID: 33576004
    [Abstract] [Full Text] [Related]

  • 12. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
    Dar SA, Das S, Ramachandran VG, Bhattacharya SN, Mustafa MD, Banerjee BD, Verma P.
    J Immunotoxicol; 2012 Jul 22; 9(1):85-95. PubMed ID: 22214240
    [Abstract] [Full Text] [Related]

  • 13. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8+ T Cells via STAT6-GATA-3 Axis in Systemic Lupus Erythematosus.
    Kato H, Perl A.
    Front Immunol; 2021 Jul 22; 12():635531. PubMed ID: 33763079
    [Abstract] [Full Text] [Related]

  • 14. Increased interleukin-4 production by NK T cells in systemic lupus erythematosus.
    Funauchi M, Yu H, Sugiyama M, Ikoma S, Ohno M, Kinoshita K, Hamada K, Kanamaru A.
    Clin Immunol; 1999 Aug 22; 92(2):197-202. PubMed ID: 10444364
    [Abstract] [Full Text] [Related]

  • 15. Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus.
    Alvarado C, Alcocer-Varela J, Llorente L, Richaud-Patin Y, Cerbon M, Alarcon-Segovia D.
    J Autoimmun; 1994 Dec 22; 7(6):763-73. PubMed ID: 7888034
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort.
    Marinho A, Carvalho C, Boleixa D, Bettencourt A, Leal B, Guimarães J, Neves E, Oliveira JC, Almeida I, Farinha F, Costa PP, Vasconcelos C, Silva BM.
    Immunol Res; 2017 Feb 22; 65(1):197-206. PubMed ID: 27423437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.
    Zhao L, Ma H, Jiang Z, Jiang Y, Ma N.
    Clin Exp Immunol; 2014 Jul 22; 177(1):212-8. PubMed ID: 24635166
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.